University of Strathclyde
Development and validation of analytical protocol for forensic investigation of benzodiazepines and other psychoactive compounds
Abstract
dc:description.abstractThe increasing workload in forensic laboratories in Kuwait often results in prolonged delays inprocessing samples, which can significantly affect the reliability of drug detection in both postmortem cases and samples from living individuals. In light of this, an assessment of the stabilityof drugs, such as the benzodiazepines (BDZs), amphetamines, opioids and other controlleddrugs like pregabalin and gabapentin which are commonly abused, becomes crucial in forensictoxicology to determine the effects of storage on the viability of these samples. Chapter two ofthis thesis addresses this issue by focusing on the development and validation of analyticalmethods to detect five benzodiazepines (alprazolam, bromazepam, clonazepam, flunitrazepam,and diazepam) that are commonly encountered during forensic investigations in Kuwait.An HPLC method was designed and refined utilising International Council for Harmonisationguidelines to ensure the accuracy, repeatability, and robustness of the method. The developedmethod was applied to perform stability assessments on the chosen BDZs, revealing that theintegrity of samples diminishes significantly after three weeks at room temperature, whilerefrigeration helps preserve sample integrity. These findings stress the importance of properstorage conditions to maintain sample validity during forensic investigations.In Chapter three, the real-world application of the developed method was explored by utilisingit to screen a collection of 48 urine samples collected from individuals under investigation forsuspected drug-related offenses. This revealed a high prevalence of BDZ use, with over 93%of samples testing positive. The detection of flunitrazepam, in particular, highlights themethod’s sensitivity and potential role in supporting criminal investigations involvingcontrolled substances.Beyond this, the research study included the development of an HPLC-MS method whichutilises a shorter column than the HPLC method, resulting in a significant reduction in analysistime required per sample while maintaining accuracy and precision. This method can also beextended to include metabolites, making it suitable for routine toxicological screening inforensic laboratories. Chapter four contains a stand-alone study conducted during the COVID19 lockdown. The experiments in this study analysed a new oxazolidinone compound (PH192) with anticonvulsant potential. The study developed a UHPLC-QToF-MS method that wassuccessfully validated and applied to the analysis of the oxazolidinone compound (PH-192). Lastly, the studies in Chapter 5 sought to incorporate a broader drug screening approach forthe identification of a wide range of substances that are often abused in Kuwait, such as theamphetamine, codeine diazepam and the controlled anticonvulsant drug pregabalin. An HPLCUV method was developed and validated, along with preliminary GC-MS analyses, to captureboth UV-active compounds and compounds with limited UV activity. The GC-MS methodrequires further refinement; however, it shows strong potential for comprehensivetoxicological screening.In summary, this research contributes to forensic science by offering reliable, validatedmethods for drug detection, identification and stability evaluation utilising equipment that arereadily available in forensic laboratories in Kuwait. The findings not only enhance localforensic capabilities but also provide a framework for broader applications in forensictoxicology worldwide.
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral-pg
- Grantor dc:publisher.institution
- University of Strathclyde
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Kamal, Husein Jasem
- Advisors dc:contributor.advisor
-
- Khadra, Ibrahim
- Rattray, Nicholas
- Dufes, Christine
- Author Identifier dc:creator.authoridentifier
-
- 201967785
Rights
- Licence dc:rights.uri
Identifiers
dc:identifier.*- Identifier
- T18071